" ( ) "

³ ( )

 (0)

 (0)

    
  1 / 1 |   | | viewdetails | |  
 # 95570
Ѳ ˲ IJ
      (uk)     (ru)     (en)      
( 20 .)   䳺
(11) 95570 (51) (2011.01)
A61K 36/30 (2006.01)
A61K 127/00
A61K 135/00
A61P 29/00
(24) 10.08.2011
(21) a201006955 (22) 07.06.2010
(41) 11.10.2010, . 19
(46) 10.08.2011, . 15
(56) UA C2 77347, 15.11.2006.
UA C2 85927, 10.03.2009.
UA A 69626, 21.10.2006.
RU C1 2363174, 10.08.2009.
RU C1 2365114, 27.08.2009.
RU C1 2266127, 20.12.2005.
RU C1 2365132, 28.04.2008.
RU C1 2369112, 10.10.2009.
RU C1 2364162, 08.04.2004.
EP A1 1281403, 05.02.2003.
(71) ֲ Ͳ (UA )
...................................................................................................................................................................
(UA )
...................................................................................................................................................................
NATIONAL PHARMACEUTICAL UNIVERSITY (UA )
(72) ³ (UA ); (UA ); (UA )
...................................................................................................................................................................
(UA ); (UA ); (UA )
...................................................................................................................................................................
Mashtaler Viktoria Volodymyrivna (UA ); Hontova Tetiana Mykolaivna (UA ); Khvorost Olha Pavlivna (UA )
(73) ֲ Ͳ, . , 53, . , 61002, (UA )
...................................................................................................................................................................
(UA )
...................................................................................................................................................................
NATIONAL PHARMACEUTICAL UNIVERSITY (UA )
(98) , -
. , 53, . , 61002,
(UA)
(54) Ѳ ˲ IJ
...................................................................................................................................................................
method for preparation of an agent with membrane-stabilizing and anti-inflammatory action
...................................................................................................................................................................
(57)
   
 
1.08254981041